HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination
- 4 December 2007
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 104 (49), 19482-19487
- https://doi.org/10.1073/pnas.0707828104
Abstract
Histone deacetylase (HDAC) inhibitors such as the phenyl hydroxamic acid PCI-24781 have emerged recently as a class of therapeutic agents for the treatment of cancer. Recent data showing synergy of HDAC inhibitors with ionizing radiation and other DNA-damaging agents have suggested that HDAC inhibitors may act, in part, by inhibiting DNA repair. Here we present evidence that HDAC enzymes are important for homologous recombinational repair of DNA double-strand breaks. Combination studies of PCI-24781 with the poly(ADP-ribose) polymerase inhibitor PJ34, an agent thought to produce lesions repaired by homologous recombination (HR), resulted in a synergistic effect on apoptosis. Immunofluorescence analysis demonstrated that HDAC inhibition caused a complete inhibition of subnuclear repair foci in response to ionizing radiation. Mechanistic investigations revealed that inhibition of HDAC enzymes by PCI-24781 led to a significant reduction in the transcription of genes specifically associated with HR, including RAD51. RAD51 protein levels were significantly decreased after 24 h of drug exposure both in vitro and in vivo. Consistent with inhibition of HR, treatment with PCI-24781 resulted in a decreased ability to perform homology directed repair of I-SceI-induced chromosome breaks in transfected CHO cells. In addition, an enhancement of cell killing was observed in Ku mutant cells lacking functional nonhomologous end joining compared with WT cells. Together these results demonstrate that HDAC enzymes are critically important to enable functional HR by controlling the expression of HR-related genes and promoting the proper assembly of HR-directed subnuclear foci.This publication has 50 references indexed in Scilit:
- Anticancer activities of histone deacetylase inhibitorsNature Reviews Drug Discovery, 2006
- A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchangeNucleic Acids Research, 2006
- CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivoMolecular Cancer Therapeutics, 2006
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Analysis of ionizing radiation-induced foci of DNA damage repair proteinsMutation research. Reviews in mutation research, 2005
- Enhanced Radiation-Induced Cell Killing and Prolongation of γH2AX Foci Expression by the Histone Deacetylase Inhibitor MS-275Cancer Research, 2004
- p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-YOncogene, 2003
- Insights into DNA recombination from the structure of a RAD51–BRCA2 complexNature, 2002
- Catalysis of ATP-Dependent Homologous DNA Pairing and Strand Exchange by Yeast RAD51 ProteinScience, 1994
- Genetic control of diploid recovery after γ-irradiation in the yeast Saccharomyces cerevisiaeMutation research. Reviews in mutation research, 1980